Neuroute vs Citeline: Fix Information Flow

Traditional players provide disconnected answers to questions that aren't related to each other, or related to you.

Over 86% of clinical trials are delayed by 6 months or more (Kim et al.,2023). 1 in 3 sites fail to recruit a single participant (Fogel,2018). The three most common trial-specific barriers to recruitment (cited by Principal Investigators) were restrictive eligibility criteria (1), complex protocols (2), and competition from nearby clinical trials (3) (Idnay et al., 2023). Historically, no one has been able to solve this problem in a meaningful way - although many have tried. There are over 500 CROs in the space and a number of vendors including Citeline or IQVIA who offer separate products for data on sites (SiteTrove), sponsors (Pharmaprojects), and studies (Trialtrove) which capture one part of the picture. Until Neuroute, there has never been a way to systematically bring every sponsor, site and study to the same place in order to map how the interactions between the specifically impact your pipeline (4).

The Solution

Use Neuroute to find out which sites have historically recruited patients with your criteria (1), de-risk complex protocols by understanding the outcomes of similar studies (2) and see all competing studies to prevent enrollment delays (3). Every single sponsor, site and study has been mapped in relation to one another, and mapped to your specific pipeline, ideas and opportunities (4).